Overview
Registration
Covid 19 Statement
Agenda
Faculty
View Archive

Accreditation/
Credit Designation

Physicians' Education Resource®, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource®, LLC, designates this enduring for a maximum of 1.50 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

An application has been made to the EACCME® for CME accreditation of this event.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Illumina, Inc.

Virtual Tumor Board®: Global Perspectives on Comprehensive NGS Profiling to Personalize Treatment in Cancer

Virtual Tumor Board®: Global Perspectives on Comprehensive NGS Profiling to Personalize Treatment in Cancer


August 14, 2020

Activity Overview

Tumor biomarkers have transformed cancer care by identifying which patients might benefit from a particular therapy, thus pinpointing effective cancer treatments faster to improve patient outcomes. Questions remain, however, on what test to use, when to use it, and how to interpret the results. This live video webcast will unearth key clinical challenges and best practices in the management of multiple tumor types with next-generation sequencing (NGS) during a facilitated discussion between 2 medical oncologists, a pathologist, and a community oncologist. The case-based program is designed to help physicians assess NGS technologies, existing and emerging biomarkers; determine appropriate treatment based on patient and tumor characteristics; and apply novel management strategies to their practices to optimize outcomes for their patients.

Acknowledgment of Commercial Support

This activity is supported by an educational grant from Illumina, Inc.

Target Audience

This educational activity is directed toward an international audience of medical oncologists, pathologists, and fellows involved in the treatment and management of patients with cancer. Nurse practitioners, nurses, physician assistants, pharmacists, researchers, and other health care professionals interested in the treatment of cancer may also participate.

Learning Objectives

Upon completion of this activity, participants will be able to:

  • Discuss the rationale supporting the role of NGS-based tumor testing strategies in patients with cancer and advantages of NGS-based testing methodology in the era of evolving biomarker research
  • Outline the role of current and emerging biomarkers in personalizing therapies in patients with cancer
  • Recognize the role of the multidisciplinary team in executing, interpreting, and applying results of NGS-based testing in cancer care
  • Utilize case-based approach to review the role of NGS-based technologies in improving outcomes for patients with cancer

Program Chair

Balazs Halmos, MD, MS
Balazs Halmos, MD, MS
Professor of Clinical Medicine
Director, Thoracic/Head and Neck Oncology
Director, Clinical Cancer Genomics
Albert Einstein College of Medicine/Montefiore Medical Center
Bronx, NY



Register

You must be logged in to PER to register for this meeting

Or Register for PER now

*Required Fields

Login Information


Registration Information


Professional Information


Specialties*

Submit
Calendar of Events
SUNMONTUESWEDTHURSFRISAT
      1
2345678
9101112131415
16171819202122
23242526272829
3031
Filter By